Delivery Order SPE2DB24D1107-SPE2DB26FZDJ8
- Not listed
- The Defense Logistics Agency awarded a $4,376.49 delivery order to AmerisourceBergen Drug Corp for AJOVY (fremanezumab) 225 mg/1.5 mL auto-injector auto-injectors, with delivery to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 14, 2025. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency (DLA) awarded a $1,943.71 firm fixed price delivery order to AmerisourceBergen Drug Corp for AJOVY (fremanezumab) 225 mg/1.5 mL syringes on September 26, 2025, with completion targeted for September 29, 2025. This non-set-aside award represents a pediatric migraine prevention medication delivery to support federal medical supply requirements. The order will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania facility, where the company maintains its...
- The Defense Logistics Agency (DLA) awarded a $1,092.00 delivery order to AmerisourceBergen Drug Corp for AJOVY 225 mg/1.5 mL auto-injector units, a pharmaceutical product used in the treatment of chronic migraine. This competitively awarded, firm fixed-price contract was issued on May 12, 2025, with an ultimate completion date of May 13, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a non-set-aside procurement, this order...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of AJOVY (eptinezumab) 225 mg/1.5 mL auto-injector units valued at $1,187.64. This firm fixed-price delivery order, issued on August 27, 2025, with an ultimate completion date of August 28, 2025, represents a non-set-aside competitive award. The pharmaceutical product will be delivered to the Place of Performance located in Conshohocken, Pennsylvania, which serves as AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,073.80 to AmerisourceBergen Drug Corp for AJOVY 225 mg/1.5 mL auto-injector units on August 11, 2025, with an ultimate completion date of August 12, 2025. This firm fixed-price delivery order, which is not subject to a set-aside designation, represents a competitive award for pharmaceutical supply to support federal medical procurement needs. The product will be delivered to AmerisourceBergen's facility in Conshohocken,...
- The Defense Logistics Agency awarded a $1,293.32 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Ajovy (fremanezumab) 225 mg/1.5 ml auto-injector units. This is a non-set-aside competitive award with an ultimate completion date of September 25, 2025. The product will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical federal healthcare vendor, AmerisourceBergen...
- The Defense Logistics Agency awarded a $6,655.88 delivery order to AmerisourceBergen Drug Corp for AJOVY 225 mg/1.5 mL auto-injector units, with a completion date of September 30, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement and is registered in the System for Award Management. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $2,597.47 to AmerisourceBergen Drug Corp for AJOVY 225 mg/1.5 ml auto-injector units, with an ultimate completion date of September 22, 2025. This is a firm fixed-price delivery order with no set-aside designation, reflecting competitive award practices. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of AJOVY 225 mg/1.5 mL syringes, with a ceiling value of $1,092.00. This competitive, firm fixed-price delivery order was awarded on September 17, 2025, with an ultimate completion date of September 18, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AJOVY is a prescription medication used primarily for the treatment of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of AJOVY 225 mg/1.5 ml syringes, valued at $1,092.00, with a completion date of August 28, 2025. This non-competitive, firm fixed-price delivery order was issued on August 27, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a single transaction under the company's broader pharmaceutical supply relationship with the...
- SPE2DB24D1107Indefinite Delivery Contract
- SPE2DB24D1107-SPE2DB26FZDJ8Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,840.30 to AmerisourceBergen Drug Corp for the supply of AJOVY (fremanezumab) 225 mg/1.5 mL auto-injector units. This contract, issued on October 8, 2025, with an ultimate completion date of October 9, 2025, represents a firm fixed-price delivery order with no set-aside designation. The award is being fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, the company's headquarters location. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. This prime contract vehicle serves as a comprehensive global pharmaceutical support mechanism enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. AJOVY is a migraine preventative medication, reflecting the company's extensive portfolio of specialty pharmaceutical products delivered through the DLA's medical supply chain to support federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.8k | 10/8/25 |